LA JOLLA PHARMACEUTICAL COMPANY et al v. GLAND PHARMA LIMITED
Plaintiff: LA JOLLA PHARMACEUTICAL COMPANY, LA JOLLA PHARMA, LLC and THE GEORGE WASHINGTON UNIVERSITY
Defendant: GLAND PHARMA LIMITED, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.,, FOSUN PHARMA USA INC. and SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Counter Claimant: FRESENIUS KABI USA LLC and FRESENIUS KABI SWISSBIOSIM GMBH
Case Number: 2:2022cv01754
Filed: March 29, 2022
Court: US District Court for the District of New Jersey
Presiding Judge: James B Clark
Referring Judge: Michael E Farbiarz
2 Judge: Julien Xavier Neals
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271 Patent Infringement
Jury Demanded By: None
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on November 16, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
November 16, 2022 Minute Entry for proceedings held before Magistrate Judge James B. Clark: Telephone Conference held on 11/16/2022. (seb)
November 16, 2022 Opinion or Order Filing 75 LETTER ORDER Denying #56 Defendant's request for leave to file a motion; Defendant may renew its request at the appropriate juncture. A Telephone Status Conference with the Parties is scheduled for 2/23/2023 at 11:30 AM, and Counsel for Defendant shall initiate the call. Signed by Magistrate Judge James B. Clark on 11/16/2022. (jd, )
November 16, 2022 Set Deadlines as to #74 MOTION to Seal. Motion set for 12/19/2022 before Magistrate Judge James B. Clark. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (jd, )
November 15, 2022 Filing 74 MOTION to Seal by GLAND PHARMA LIMITED. (Attachments: #1 Statement In Lieu of Brief, #2 Certification of Justin T. Quinn, #3 Findings of Fact, Conclusions of Law & Order, #4 Plaintiffs brief in support of their motion to join parties and amend complaint (Redacted), #5 N. Giove Decl. (Redacted), #6 Ex. 2 (Redacted), #7 Ex. 3 (Redacted), #8 Ex. 6 (Redacted), #9 Ex. 7 (Redacted), #10 Ex. 8 (Redacted), #11 Glands opposition to Plaintiffs motion to amend (Redacted), #12 Plaintiffs' reply (Redacted), #13 Certificate of Service)(QUINN, JUSTIN)
November 10, 2022 Opinion or Order Filing 73 Discovery Confidentiality Order. Signed by Magistrate Judge James B. Clark on 11/10/2022. (jd, )
November 9, 2022 Filing 72 Letter from Charles H. Chevalier to The Honorable James B. Clark, III, U.S.M.J. (CHEVALIER, CHARLES)
October 31, 2022 Filing 71 REPLY BRIEF to Opposition to Motion filed by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY re #59 MOTION to Amend/Correct #1 Complaint,, and Join Parties (CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court.
October 24, 2022 Filing 70 BRIEF in Opposition filed by GLAND PHARMA LIMITED re #59 MOTION to Amend/Correct #1 Complaint,, and Join Parties (Attachments: #1 Declaration of Jieun Lee, #2 Exhibit 1)(QUINN, JUSTIN)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court.
October 18, 2022 Opinion or Order Filing 69 LETTER ORDER that the court will discuss defendant's request for leave to file a motion during 11/16/2022 telephonic conference. Signed by Magistrate Judge James B. Clark on 10/18/2022. (lag, )
October 18, 2022 Filing 68 LETTER ORDER that the parties are not required to seek the court's leave prior to filing a motion to amend (lag, ) Modified on 10/18/2022 (lag, ).
October 18, 2022 Filing 67 Letter from Charles H. Chevalier, Esq. to the Honorable James B. Clark, III, U.S.M.J. re #66 Letter. (CHEVALIER, CHARLES)
October 17, 2022 Filing 66 Letter from Justin T. Quinn, Esq. to the Honorable James B. Clark, III, U.S.M.J re #59 MOTION to Amend/Correct #1 Complaint,, and Join Parties. (QUINN, JUSTIN)
October 17, 2022 Filing 65 Letter from Justin T. Quinn, Esq. to the Honorable James B. Clark, III, U.S.M.J re #63 Letter,,. (QUINN, JUSTIN)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court.
October 17, 2022 Filing 64 Letter from Charles H. Chevalier to The Honorable James B. Clark, III, U.S.M.J. (Attachments: #1 Text of Proposed Order)(CHEVALIER, CHARLES)
October 13, 2022 Filing 63 Letter from Charles H. Chevalier, Esq. to the Honorable James B. Clark, III, U.S.M.J. re #56 Letter,,. (CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court.
October 11, 2022 Opinion or Order Filing 62 LETTER ORDER granting #61 Letter request extending the deadline to submit a proposed Discovery Confidentiality Order by one additional week, until 10/17/2022. Signed by Magistrate Judge James B. Clark on 10/11/2022. (jd, )
October 11, 2022 Set Deadlines as to #59 MOTION to Amend/Correct #1 Complaint and Join Parties. Motion set for 11/7/2022 before Magistrate Judge James B. Clark. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (jd, )
October 10, 2022 Filing 61 Letter from Justin T. Quinn, Esq. to the Honorable James B. Clark, III, U.S.M.J. requesting one-week extension. (QUINN, JUSTIN)
October 7, 2022 Filing 60 BRIEF in Support filed by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY re #59 MOTION to Amend/Correct #1 Complaint,, and Join Parties (Attachments: #1 Declaration of Nicholas F. Giove, Esq., #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10)(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court.
October 7, 2022 Filing 59 MOTION to Amend/Correct #1 Complaint,, and Join Parties by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY. (Attachments: #1 Text of Proposed Order)(CHEVALIER, CHARLES)
October 3, 2022 Opinion or Order Filing 58 LETTER ORDER granting #57 Plaintiff's Letter Requesting a two week extension of time to respond to all issues raised in the letter re #56 , until 10/13/2022. Signed by Magistrate Judge James B. Clark on 10/3/2022. (jd, )
September 30, 2022 Filing 57 Letter from Charles H. Chevalier, Esq. to the Honorable James B. Clark, III, U.S.M.J. re #56 Letter,,. (CHEVALIER, CHARLES)
September 29, 2022 Filing 56 Letter from Justin T. Quinn, Esq. to the Honorable James B. Clark, III, U.S.M.J., requesting leave to file a motion for judgment on the pleadings pursuant to Fed. R. Civ. P. 12(c) re #42 Scheduling Order. (QUINN, JUSTIN)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court.
September 27, 2022 Opinion or Order Filing 55 LETTER ORDER granting #54 Letter extending the deadline for the Parties to submit a proposed Discovery Confidentiality Order by two additional weeks, until 10/10/2022. Signed by Magistrate Judge James B. Clark on 9/27/2022. (jd, )
September 26, 2022 Filing 54 Letter from Justin T. Quinn, Esq. to the Honorable James B. Clark, III, U.S.M.J. (QUINN, JUSTIN)
September 13, 2022 Opinion or Order Filing 53 LETTER ORDER granting #52 Letter extending the deadline for Parties to submit a proposed Discovery Confidentiality Order by two weeks, until 9/26/2022. Signed by Magistrate Judge James B. Clark on 9/13/2022. (jd, )
September 12, 2022 Filing 52 Letter from Justin T. Quinn, Esq. (on behalf of all Parties) to the Honorable James B. Clark, III, U.S.M.J. re #51 Order. (QUINN, JUSTIN)
August 30, 2022 Opinion or Order Filing 51 LETTER ORDER granting #50 Letter extending the deadline for Parties to submit a proposed Discovery Confidentiality Order by two weeks, until 9/12/2022. Signed by Magistrate Judge James B. Clark on 8/30/2022. (jd, )
August 29, 2022 Filing 50 Letter from Justin T. Quinn, Esq. to the Honorable James B. Clark, III, U.S.M.J. (QUINN, JUSTIN)
August 23, 2022 Opinion or Order Filing 49 LETTER ORDER granting #48 Extending the Deadline for the Parties to submit a proposed Discovery Confidentiality Order, until 8/29/2022. Signed by Magistrate Judge James B. Clark on 8/23/2022. (jd, )
August 22, 2022 Filing 48 Letter from Justin T. Quinn, Esq. to the Honorable James B. Clark, III, U.S.M.J. requesting additional one-week extension to submit proposed Discovery Confidentiality Order. (QUINN, JUSTIN)
August 15, 2022 Opinion or Order Filing 47 LETTER ORDER re #46 Letter requesting an additional one-week extension to submit proposed Discovery Confidentiality Order. Signed by Magistrate Judge James B. Clark on 8/15/2022. (jd, )
August 12, 2022 Filing 46 Letter from Justin T. Quinn, Esq. to the Honorable James B. Clark, III, U.S.M.J. requesting additional one-week extension to submit proposed Discovery Confidentiality Order re #45 Order. (QUINN, JUSTIN)
August 10, 2022 Opinion or Order Filing 45 LETTER ORDER granting #44 Letter request for a one week extension to submit a proposed Discovery Confidentiality Order, until 8/15/2022. Signed by Magistrate Judge James B. Clark on 8/10/2022. (jd, )
August 8, 2022 Filing 44 Letter from Justin T. Quinn, Esq. to the Honorable James B. Clark, III, U.S.M.J. requesting one-week extension to submit proposed Discovery Confidentiality Order re #42 Scheduling Order. (QUINN, JUSTIN)
August 2, 2022 Filing 43 NOTICE of Appearance by CHRISTINE A. GADDIS on behalf of LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY (GADDIS, CHRISTINE)
August 1, 2022 Filing 41 Letter from Charles H. Chevalier, Esq. to the Honorable James B. Clark, III, U.S.M.J.. (CHEVALIER, CHARLES)
July 27, 2022 Opinion or Order Filing 42 PRETRIAL SCHEDULING ORDER. Signed by Magistrate Judge James B. Clark on 7/27/2022. (jd,)
July 27, 2022 Minute Entry for proceedings held before Magistrate Judge James B. Clark: Scheduling Conference held on 7/27/2022. (seb)
July 25, 2022 Opinion or Order Filing 40 LETTER ORDER re #39 Adjourning Initial Conference set for 7/27/2022 will instead commence at 2:00 PM before Magistrate Judge James B. Clark. Signed by Magistrate Judge James B. Clark on 7/25/2022. (jd, ) Modified on 7/25/2022 (jd, ).
July 22, 2022 Filing 39 Letter from Charles H. Chevalier, Esq. to the Honorable James B. Clark, III, U.S.M.J. re #38 Order, Set Hearings. (CHEVALIER, CHARLES)
July 21, 2022 Opinion or Order Filing 38 LETTER ORDER Adjourning Initial Conference set for 7/25/2022 to 7/27/2022 at 11:00 AM. Signed by Magistrate Judge James B. Clark on 7/21/2022. (jd,)
July 18, 2022 Filing 37 Exhibit to #36 Joint Discovery Plan,, by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY. (CHEVALIER, CHARLES)
July 18, 2022 Filing 36 Joint Discovery Plan by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY.(CHEVALIER, CHARLES)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court.
July 14, 2022 Pro Hac Vice counsel, IMRON T. ALY, JOHN K. HSU, KEVIN M. NELSON, and JIEUN LEE have been added to receive Notices of Electronic Filings. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (jd, )
July 13, 2022 Filing 35 Notice of Request by Pro Hac Vice Jieun Lee to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13555145.) (QUINN, JUSTIN)
July 13, 2022 Filing 34 Notice of Request by Pro Hac Vice Kevin M. Nelson to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13555141.) (QUINN, JUSTIN)
July 13, 2022 Filing 33 Notice of Request by Pro Hac Vice John K. Hsu to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13555138.) (QUINN, JUSTIN)
July 13, 2022 Filing 32 Notice of Request by Pro Hac Vice Imron T. Aly to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13555130.) (QUINN, JUSTIN)
July 11, 2022 Opinion or Order Filing 31 CONSENT ORDER granting #30 Application admitting Pro Hac Vice as to IMRON T. ALY, JOHN K. HSU, KEVIN M. NELSON, AND JIEUN LEE. Signed by Magistrate Judge James B. Clark on 7/11/2022. (jd, )
July 8, 2022 Filing 30 Letter from Justin T. Quinn, Esq. to the Honorable James B. Clark, III, U.S.M.J. enclosing application for the pro hac vice admission of counsel. (Attachments: #1 Declaration of Justin T. Quinn, #2 Declaration of Imron T. Aly, #3 Declaration of John K. Hsu, #4 Declaration of Kevin M. Nelson, #5 Declaration of Jieun Lee, #6 Text of Proposed Order)(QUINN, JUSTIN)
June 7, 2022 Filing 29 NOTICE of Appearance by AHMED MUHAMMED TAN RIAZ on behalf of GLAND PHARMA LIMITED (RIAZ, AHMED)
June 3, 2022 Filing 28 ANSWER to Counterclaim by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY.(CHEVALIER, CHARLES)
May 24, 2022 Opinion or Order Filing 27 STIPULATION AND ORDER OF DISMISSAL without Prejudice, Defendants FOSUN PHARMA USA INC. and SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. terminated. Signed by Judge Julien Xavier Neals on 5/24/2022. (jd,)
May 23, 2022 Filing 26 Letter from Charles H. Chevalier, Esq. to the Honorable Julien X. Neals, U.S.D.J.. (Attachments: #1 Stipulation of Dismissal)(CHEVALIER, CHARLES)
May 17, 2022 Opinion or Order Filing 25 LETTER ORDER granting a one-week extension of time in which defendant may file answer, from 5/16/2022 to 5/23/2022, etc. Signed by Magistrate Judge James B. Clark on 5/17/2022. (lag, )
May 16, 2022 Filing 24 Letter from Justin T. Quinn, Esq. to the Hon. Julien X. Neals, U.S.D.J. requesting one-week extension of deadline to file responsive pleading (on consent) re Update Answer Due Deadline. (QUINN, JUSTIN)
May 13, 2022 Clerk`s Text Order - The document #23 Application for Clerk's Order to Ext Answer/Proposed Order submitted by THE GEORGE WASHINGTON UNIVERSITY, LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY has been GRANTED. The answer due date has been set for 6/3/2022. (jd,)
May 12, 2022 Pro Hac Vice counsel, EDGAR H. HAUG, SANDRA KUZMICH, NICHOLAS F. GIOVE and ANNA N. LUKACHER, has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (jd,)
May 11, 2022 Filing 23 APPLICATION/PETITION for Extension of Time to Answer, Move or Otherwise Reply pursuant to Local Civil Rule 6.1(b) for by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY. (CHEVALIER, CHARLES)
May 9, 2022 Filing 22 Notice of Request by Pro Hac Vice Anna N. Lukacher to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13397828.) (CHEVALIER, CHARLES)
May 9, 2022 Filing 21 Notice of Request by Pro Hac Vice Nicholas F. Giove to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13397824.) (CHEVALIER, CHARLES)
May 9, 2022 Filing 20 Notice of Request by Pro Hac Vice Sandra Kuzmich, Ph.D. to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13397822.) (CHEVALIER, CHARLES)
May 9, 2022 Filing 19 Notice of Request by Pro Hac Vice Edgar H. Haug to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-13397820.) (CHEVALIER, CHARLES)
May 9, 2022 Opinion or Order Filing 18 ORDER granting #17 Application for the Pro Hac Vice Admission of ANNA N. LUKACHER. etc. Signed by Magistrate Judge James B. Clark on 5/9/2022. (jd)
May 6, 2022 Filing 17 APPLICATION/PETITION for admission pro hac vice of Anna N. Lukacher for by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY. (Attachments: #1 Declaration of Charles H. Chevalier, Esq., #2 Certification of Anna N. Lukacher, Esq., #3 Proposed Order)(CHEVALIER, CHARLES)
May 5, 2022 Opinion or Order Filing 16 ORDER granting #15 Plaintiff's Application admitting pro hac vice counsel EDGAR H. HAUG, SANDRA KUZMICH, Ph.D., and NICHOLAS F. GIOVE. etc. Signed by Magistrate Judge James B. Clark on 5/5/2022. (jd)
May 4, 2022 Filing 15 APPLICATION/PETITION for admission pro hac vice of Edgar H. Haug, Sandra Kuzmich, Ph.D., and Nicholas F. Giove for by LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY. (Attachments: #1 Declaration of Charles H. Chevalier, Esq., #2 Certification of Edgar H. Haug, Esq., #3 Certification of Sandra Kuzmich, Ph.D., Esq., #4 Certification of Nicholas F. Giove, Esq., #5 Proposed Order)(CHEVALIER, CHARLES)
May 3, 2022 Opinion or Order Filing 14 LETTER ORDER: Initial Conference set for 7/25/2022 at 10:00 AM before Magistrate Judge James B. Clark. Signed by Magistrate Judge James B. Clark on 5/3/2022. (seb)
May 2, 2022 Clerk`s Text Order - The document #11 Application for Clerk's Order to Ext Answer/Proposed Order submitted by FOSUN PHARMA USA INC. has been GRANTED. The answer due date has been set for 5/16/2022. (jd)
April 29, 2022 Filing 13 Corporate Disclosure Statement by GLAND PHARMA LIMITED. (QUINN, JUSTIN)
April 29, 2022 Filing 12 ANSWER to Complaint , COUNTERCLAIM against LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY by GLAND PHARMA LIMITED.(QUINN, JUSTIN)
April 29, 2022 Filing 11 Application and Proposed Order for Clerk's Order to extend time to answer as to Defendant Fosun Pharma USA Inc... (QUINN, JUSTIN)
April 29, 2022 Filing 10 NOTICE of Appearance by JUSTIN TAYLOR QUINN on behalf of FOSUN PHARMA USA INC., GLAND PHARMA LIMITED (QUINN, JUSTIN)
April 20, 2022 Filing 9 NOTICE of Appearance by STEPHEN R. DONAT on behalf of LA JOLLA PHARMA, LLC, LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY (DONAT, STEPHEN)
April 11, 2022 Filing 8 SUMMONS Returned Executed by LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY, LA JOLLA PHARMA, LLC. FOSUN PHARMA USA INC. served on 4/11/2022, answer due 5/2/2022. (CHEVALIER, CHARLES)
April 11, 2022 Filing 7 ACKNOWLEDGMENT OF SERVICE Executed by LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY, LA JOLLA PHARMA, LLC. GLAND PHARMA LIMITED served on 4/8/2022, answer due 4/29/2022. (CHEVALIER, CHARLES)
March 31, 2022 Filing 6 SUMMONS ISSUED as to FOSUN PHARMA USA INC., GLAND PHARMA LIMITED, SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jd)
March 31, 2022 Filing 5 AO120 Patent Form filed. (Attachments: #1 Complaint and Exhibits) (jd) (Attachment 1 replaced on 3/31/2022) (jd, ).
March 29, 2022 Case Assigned to Judge Julien Xavier Neals and Magistrate Judge James B. Clark. (ak, )
March 29, 2022 Filing 4 Corporate Disclosure Statement by THE GEORGE WASHINGTON UNIVERSITY identifying NONE as Corporate Parent.. (CHEVALIER, CHARLES)
March 29, 2022 Filing 3 Corporate Disclosure Statement by LA JOLLA PHARMACEUTICAL COMPANY identifying NONE as Corporate Parent.. (CHEVALIER, CHARLES)
March 29, 2022 Filing 2 Corporate Disclosure Statement by LA JOLLA PHARMA, LLC identifying LA JOLLA PHARMACEUTICAL COMPANY as Corporate Parent.. (CHEVALIER, CHARLES)
March 29, 2022 Filing 1 COMPLAINT against FOSUN PHARMA USA INC., GLAND PHARMA LIMITED, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., ( Filing and Admin fee $ 402 receipt number ANJDC-13294640) , Related Case Selected, filed by LA JOLLA PHARMACEUTICAL COMPANY, THE GEORGE WASHINGTON UNIVERSITY, LA JOLLA PHARMA, LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Civil Cover Sheet, #12 Certification Pursuant to Local Civil Rule 11.2)(CHEVALIER, CHARLES)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System

Search for this case: LA JOLLA PHARMACEUTICAL COMPANY et al v. GLAND PHARMA LIMITED
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: LA JOLLA PHARMACEUTICAL COMPANY
Represented By: CHARLES H. CHEVALIER
Represented By: STEPHEN R. DONAT
Represented By: CHRISTINE A. GADDIS
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: LA JOLLA PHARMA, LLC
Represented By: CHARLES H. CHEVALIER
Represented By: STEPHEN R. DONAT
Represented By: CHRISTINE A. GADDIS
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: THE GEORGE WASHINGTON UNIVERSITY
Represented By: CHARLES H. CHEVALIER
Represented By: STEPHEN R. DONAT
Represented By: CHRISTINE A. GADDIS
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: GLAND PHARMA LIMITED
Represented By: JUSTIN TAYLOR QUINN
Represented By: AHMED MUHAMMED TAN RIAZ
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Shanghai Fosun Pharmaceutical (Group) Co., Ltd.,
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: FOSUN PHARMA USA INC.
Represented By: JUSTIN TAYLOR QUINN
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: FRESENIUS KABI USA LLC
Represented By: JUSTIN TAYLOR QUINN
Represented By: AHMED MUHAMMED TAN RIAZ
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: FRESENIUS KABI SWISSBIOSIM GMBH
Represented By: JUSTIN TAYLOR QUINN
Represented By: AHMED MUHAMMED TAN RIAZ
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?